CancerIFP

About CeGaT

CeGaT is an established, privately-held German leader in genetic diagnostics and high-throughput sequencing services. The company serves a dual market of clinical diagnostics for rare diseases and oncology, alongside a robust B2B segment supporting pharmaceutical R&D and clinical trials. With a strong foundation in accredited laboratory operations and a continuous pipeline of service innovations like HiFi Whole Genome Sequencing and spatial transcriptomics, CeGaT is positioned at the intersection of precision medicine and advanced genomic research. Its business model is primarily service-based, generating revenue from diagnostic testing and contract research services.

Therapeutic Areas

Other Tumor Microenvironment Analysis Drugs